Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Aalto Scientific, Ltd. · Predicate Candidate Screening

35 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

66 daysmedian FDA review time
268 days90th percentile
35clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K163629Audit MicroControls Linearity FD Tumor Markers IIAalto Scientific, Ltd.2017-03-10780
K161874Audit MicroControls Linearity DROP LQ Blood GlucoseAalto Scientific, Ltd.2016-08-10330
K143571Audit MicroControls Linearity LQ Cystatin-CAalto Scientific, Ltd.2015-01-23370
K143573Audit MicroControls Linearity FD Tumor Markers IIAalto Scientific, Ltd.2015-01-16300
K143026Audit MicroControls Linearity FD Unsaturated Iron Binding CaAalto Scientific, Ltd.2014-11-21310
K142978Audit MicroControls Linearity LQ Special DiabetesAalto Scientific, Ltd.2014-11-20360
K130762AUDIT MICROCV THERAPEUTIC DRUG (TDM) LINEARITY SETAalto Scientific, Ltd.2013-04-29400
K130764AUDIT MICROCV VITAMIN D LINEARITY SETAalto Scientific, Ltd.2013-04-26370
K130157AUDIT MICROCV BETA-HYDROXYBUTYRIC ACID LINEARITY SETAalto Scientific, Ltd.2013-03-19550
K112742AUDIT MICROLQ SPINAL FLUID CONTROLAalto Scientific, Ltd.2012-06-152680
K111964AUDIT MICROCV URINE/FLUIDS CHEMISTRY LINEARITYAalto Scientific, Ltd.2012-03-022350
K112143AUDIT MICROCV T-UPTAKE LINEARITYAalto Scientific, Ltd.2012-01-311890
K112705AUDIT(R) MICROLQ(TM) SERUM PROTEIN CONTROLAalto Scientific, Ltd.2012-01-241300
K100716AUDIT MICROCV D-DIMER LINEARITY SET, MODEL K717M-5Aalto Scientific, Ltd.2011-06-234680
K103601AUDIT MICROCV IMMUNOASSAY LINEARITY SETAalto Scientific, Ltd.2011-06-101840
K101216AUDIT MICROCV PROTEIN LINEARITY SETAalto Scientific, Ltd.2011-01-142590
K102617AUDIT MICROCV CARDIAC MARKERS LINEARITY SETAalto Scientific, Ltd.2011-01-101220
K100715AUDIT MICROCV HOMOCYSTEINE LINEARITY SET, MODEL 704M-5Aalto Scientific, Ltd.2010-12-232860
K101427AUDIT MICROCV HS-CRP LINEARITY SETAalto Scientific, Ltd.2010-12-232160
K100718AUDIT MICROCV AMMONIAN/ETHANOL LINEARITY SET, MODEL K712M-5Aalto Scientific, Ltd.2010-09-031750
K101226AUDIT MICROCV RF/CRP LINEARITY SETAalto Scientific, Ltd.2010-08-311200
K101434AUDIT MICROCV PROCALCITONIN LINEARITYAalto Scientific, Ltd.2010-07-22620
K100750AUDIT MICROCV ASO LINEARITY SET, MODEL K721M-5Aalto Scientific, Ltd.2010-05-21660
K082714AUDIT MICROCV THERAPEUTIC DRUG (TDM) LINEARITY SET, MODEL K7Aalto Scientific, Ltd.2008-11-19630
K082717AUDIT MICROCV TUMOR MARKERS LINEARITY SET, MODEL K719M-5Aalto Scientific, Ltd.2008-10-30430
K070223AUDIT MICROCV LIPIDS LINEARITY SET (LOW)Aalto Scientific, Ltd.2007-03-13480
K062668AUDIT MICROCV IMMUNOASSAY LINEARITY SETAalto Scientific, Ltd.2006-10-16380
K042318AUDIT MICROCV GENERAL CHEMISTRY LINEARITY SETAalto Scientific, Ltd.2004-12-091050
K032122AUDIT MICROCONTROLS MICROFD BNP CONTROLAalto Scientific, Ltd.2003-09-09620
K020618AALTO SCIENTIFIC MIRCO HEMATOCRIT CONTROLAalto Scientific, Ltd.2002-05-14780
K952126AALTO SCIENTIFIC LIQUID CEREBROSPINAL FLUID CONTROLS LEVELS Aalto Scientific, Ltd.1996-02-292970
K954074AALTO SCIENTIFIC LIQUID CARDIAC CONTROLAalto Scientific, Ltd.1995-10-07380
K952720AALTO SCIENTIFIC LTD. GLYCATED HEMOGLOBIN CONTROL LEVELS I &Aalto Scientific, Ltd.1995-09-20973
K951435AALTO SCIENTIFIC SWEAT CHLORIDE REFERENCE MATERIALAalto Scientific, Ltd.1995-05-02360
K820360AALTO LDH ISOENZYME CONTROL SERUMAalto Scientific, Ltd.1982-03-04230

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda